LetsGetChecked

Veritas Intercontinental, S.L., based in Madrid, Spain, specializes in whole genome sequencing and interpretation services. Founded in 2004, the company offers a range of genetic tests designed to provide insights into hereditary diseases, medication responses, and ancestry. Its key offerings include myGenome, which assesses risks for hereditary diseases and medication responses; myNewbornDNA, aimed at identifying genetic diseases in newborns; myCancerRiskDNA, which evaluates cancer risk; and myDiagnostic, for patients with potential hereditary genetic conditions. Veritas aims to empower individuals to enhance their health and longevity through actionable genetic information. The company has been recognized for its innovative contributions to genomics, having received accolades from MIT Technology Review, Fast Company, and CNBC.

Veritas Genetics is a provider of a genetic testing platform intended to empower people to live healthier and longer. The company's genetic technology can detect a wider range of variations in a gene than are typically found in next-generation sequencing and offers a screening test for hereditary breast and ovarian cancer risk, enabling clinical researchers and physicians in order to make informed decisions.

BioIQ also known as Jentryx is a health improvement technology company that has implemented the industry’s first integrated, customizable and measurable approach to optimizing investments in corporate health and wellness programs. The company’s unique health screening platform, ecosystem of health improvement tools, and proven methodology for obtaining quantifiable wellness insights are serving beneficiaries across the United States. BioIQ works with some of the largest employers and health companies in the nation and has launched over 3,000 successful health improvement programs since its inception in 2005.